Skip to main content

Table 2 Vitamin D deficiency and PSI at enrollment (241 patients)

From: Impact of vitamin D supplementation on the clinical outcomes of COVID-19 pneumonia patients: a single-center randomized controlled trial

Vitamin D deficiency

PSI at enrollment, n (%)

(n = 241)

Low, ≤ 90

Moderate, 91–130

High, > 130

Optimal vitamin D (30–60 ng/mL)

50 (20.75)

8 (3.32)

1 (0.41)

Vitamin D insufficiency (20–29.99 ng/mL)

102 (42.32)

3 (1.25)

0 (0.00)

Vitamin D deficiency (12–19.99 ng/mL)

57 (23.65)

6 (2.50)

1 (0.41)

Severe vitamin D deficiency (< 12 ng/mL)

12 (4.98)

1 (0.41)

0 (0.00)

  1. PSI pneumonia severity index